Journal details
CANCER IMMUNOLOGY IMMUNOTHERAPY
SPRINGER · ISSN 0340-7004 · eISSN 1432-0851
SCIEScopusMEDLINEPubMedPMCDOAJ
Overview
CANCER IMMUNOLOGY IMMUNOTHERAPY is a Oncology · Immunology journal published by SPRINGER (United States). Use this page to check its impact factor, JCR quartile, CAS zone and indexing before you submit. Always confirm the scope, APC and policies on the journal's official website.
Publication output
2026: 169 articles · 2025: 374 articles · 2024: 301 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CANCER IMMUNOLOGY IMMUNOTHERAPY?
The impact factor recorded for CANCER IMMUNOLOGY IMMUNOTHERAPY is 5.8 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CANCER IMMUNOLOGY IMMUNOTHERAPY?
CANCER IMMUNOLOGY IMMUNOTHERAPY is listed in CAS Zone 3.
Which databases index CANCER IMMUNOLOGY IMMUNOTHERAPY?
CANCER IMMUNOLOGY IMMUNOTHERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.